Clinical pharmacokinetics of moricizine

American Journal of Cardiology - Tập 65 - Trang 21-25 - 1990
Lyle A. Siddoway1, Sorell L. Schwartz1, Jean T. Barbey1, Raymond L. Woosley1
1From the Division of Clinical Pharmacology, Departments of Medicine and Pharmacology, Georgetown University of School of Medicine, Washington, D.C., USA

Tài liệu tham khảo

Woosley, 1987, Pharmacokinetics of moricizine HCl, Am J Cardiol, 60, 35F, 10.1016/0002-9149(87)90718-1 Piotrovski, 1982, Pharmacokinetics of ethmozine after a single intravenous injection, Kardiologiia, 22, 75 Biollaz, 1985, Cimetidine inhibition of ethmozine metabolism, Clin Pharmacol Ther, 37, 665, 10.1038/clpt.1985.108 MacFarland, 1985, Assessment of the potential pharmacokinetic interaction between digoxin and ethmozine, J Clin Pharmacol, 25, 138, 10.1002/j.1552-4604.1985.tb02814.x Kennedy, 1986, Serum digoxin concentrations during Ethmozine therapy, Am Heart J, 111, 667, 10.1016/0002-8703(86)90096-7 Pratt, 1987, Antiarrhythmic efficacy of ethmozine (moricizine HCl) compared with disopyramide and propranolol, Am J Cardiol, 60, 52F, 10.1016/0002-9149(87)90722-3 Butman, 1987, Comparison of ethmozine to propranolol and the combination for ventricular arrhythmias, Am J Cardiol, 60, 603, 10.1016/0002-9149(87)90313-4